Literature DB >> 889894

The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat.

R L Gambardella, K E Richardson.   

Abstract

The metabolic pathway by which L-[14C1]phenylalanine, L-[14C1]tyrosine, L-[14C1]tryptophan, and L-[14C1]ascorbic acid are converted to [14C]oxalate have been investigated in the male rate. Only [14C]oxalate was detected in the urine of rats injected with L-[14C1]ascorbic acid, but [14C]-labeled oxalate, glycolate, glyoxylate, glycolaldehyde, glycine, and serine were recovered from the [14C1]-labeled aromatic amino acids. DL-Phenyllactate, an inhibitor of glycolic acid oxidase and glycolic acid dehydrogenase, reduced the amount of [14C]oxalate recovered in the urine of rats given the [14C1]-labeled aromatic amino acids, but increased the amount of [14C]glycolate formed from L-[14C1]phenylalanine and L-[14C1]tyrosine and the amount of [14C]glycolate produced from [14C1]tryptophan. Based on the [14C]labeled intermediates identified and the relative distribution of the radioactivity, it is postulated that phenylalanine and tyrosine are converted to oxalate via glycolate which is oxidized directly to oxalate by glycolic acid dehydrogenase. Tryptophan is metabolized via glyoxylate which is oxidized directly to oxalate by glycolic acid oxidase. Neither glycolate, glyoxylate, glycolic acid oxidase or glycolic acid dehydrogenase are involved in the formation of oxalate from ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889894     DOI: 10.1016/0304-4165(77)90238-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate.

Authors:  John Knight; Dean G Assimos; Michael F Callahan; Ross P Holmes
Journal:  Metabolism       Date:  2010-10-30       Impact factor: 8.694

2.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

Review 3.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

4.  Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion.

Authors:  John Knight; Linda H Easter; Rebecca Neiberg; Dean G Assimos; Ross P Holmes
Journal:  Urol Res       Date:  2009-01-29

Review 5.  Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.

Authors:  Joseph J Crivelli; Tanecia Mitchell; John Knight; Kyle D Wood; Dean G Assimos; Ross P Holmes; Sonia Fargue
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

6.  A genome-scale modeling approach to study inborn errors of liver metabolism: toward an in silico patient.

Authors:  Roberto Pagliarini; Diego di Bernardo
Journal:  J Comput Biol       Date:  2013-03-06       Impact factor: 1.479

Review 7.  Adducted proteins for identification of endogenous electrophiles.

Authors:  M Törnqvist; A Kautiainen
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

8.  Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.

Authors:  Stoyanka S Atanassova; Ivan S Gutzow
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.